K

KAHR-medical Ltd.

32 employees

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Pharmaceutical

Date founded

2005

Funding rounds raised

Total raised

$47M

from 15 investors over 15 rounds

K

KAHR-medical Ltd. raised $47M on June 16, 2021

Investors: Cancer Focus Fund, Hadasit Bio-Holdings Ltd., Flerie Invest, Peregrine Ventures and DAFNA Capital Management, LLC

K

KAHR-medical Ltd. raised $18M on February 25, 2020

Investors: Hadasit Bio-Holdings Ltd. and Flerie Invest

K

KAHR-medical Ltd. raised $12M on December 1, 2015

Investors: DSC Investment, Korea Investment Partners and Flerie Invest

K

KAHR-medical Ltd. raised $2.5M on September 1, 2013

Investors: Sanofi Ventures and Flerie Invest

K

KAHR-medical Ltd. raised $3M on April 14, 2011

Investors: Hadasit Bio-Holdings Ltd.

K

KAHR-medical Ltd. raised $1.5M on December 1, 2009

Investors: Hadasit Bio-Holdings Ltd.

K

KAHR-medical Ltd. raised $500K on January 28, 2009

Investors: Hadasit Bio-Holdings Ltd.

FAQ